The Human Alzheimer Disease Project: A New Call to Arms.
作者信息
Rosenberg Roger N, Petersen Ronald C
机构信息
Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas2Editor, JAMA Neurology.
Alzheimer's Disease Research Center, Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota.
出版信息
JAMA Neurol. 2015 Jun;72(6):626-8. doi: 10.1001/jamaneurol.2015.67.
Abstract
摘要
相似文献
1
The Human Alzheimer Disease Project: A New Call to Arms.人类阿尔茨海默病项目：新的战斗号角。
JAMA Neurol. 2015 Jun;72(6):626-8. doi: 10.1001/jamaneurol.2015.67.
2
Biomarkers: call on industry to share.生物标志物：呼吁行业分享。
Nature. 2011 Feb 10;470(7333):175. doi: 10.1038/470175d.
3
Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community.阿尔茨海默病公私合作伙伴关系：全球非营利组织界概况
Alzheimers Dement. 2013 Jul;9(4):466-71. doi: 10.1016/j.jalz.2013.05.1761.
4
Evaluation of the public-private mix: how economics can contribute to tuberculosis control.公私混合评估：经济学如何助力结核病控制。
Expert Rev Anti Infect Ther. 2010 May;8(5):489-91. doi: 10.1586/eri.10.37.
5
Pierre Meulien.皮埃尔·默利安
Nat Rev Drug Discov. 2015 Aug;14(8):521. doi: 10.1038/nrd4698.
6
IDF's Global Diabetes Forum: driving multisectoral partnerships for diabetes.国际糖尿病联合会全球糖尿病论坛：推动糖尿病领域的多部门伙伴关系
Diabetes Res Clin Pract. 2012 Jun;96(3):416-7. doi: 10.1016/j.diabres.2012.05.009.
7
Europe sees mixed results from public-private partnerships for building and managing health care facilities and services.欧洲在公私合作伙伴关系建设和管理医疗保健设施和服务方面取得了喜忧参半的结果。
Health Aff (Millwood). 2013 Jan;32(1):146-54. doi: 10.1377/hlthaff.2011.1223.
8
Academia-pharma partnerships for novel drug discovery: essential or nice to have?学术界与制药公司合作进行新药研发：是必不可少还是可有可无？
Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17.
9
Partners in discovery.探索伙伴。
Nature. 2018 Mar 22;555(7697):S60. doi: 10.1038/d41586-018-02897-z.
10
Case studies: The price is right.案例研究：价格合理。
Health Serv J. 2011 Sep 29;Suppl:22-3.
引用本文的文献
1
Genomics of Alzheimer Disease: A Review.阿尔茨海默病的基因组学：综述。
JAMA Neurol. 2016 Jul 1;73(7):867-74. doi: 10.1001/jamaneurol.2016.0301.
2
Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia.理想心血管健康与血管性脑损伤及新发痴呆症的关联
Stroke. 2016 May;47(5):1201-6. doi: 10.1161/STROKEAHA.115.012608. Epub 2016 Apr 12.
本文引用的文献
1
Exceptional opportunities in medical science: a view from the National Institutes of Health.医学领域的非凡机遇：来自美国国立卫生研究院的视角
JAMA. 2015 Jan 13;313(2):131-2. doi: 10.1001/jama.2014.16736.
2
The Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) initiative and neurology.通过推进创新神经技术开展脑研究（BRAIN）计划与神经学
JAMA Neurol. 2014 Jun;71(6):675-6. doi: 10.1001/jamaneurol.2014.411.
3
The G8 Dementia Research Summit--a starter for eight?八国集团痴呆症研究峰会——八人首发阵容？
Lancet. 2013 Dec 14;382(9909):1968-9. doi: 10.1016/S0140-6736(13)62426-5.
4
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.《1990-2010 年美国健康状况：疾病、伤害及危险因素负担》
JAMA. 2013 Aug 14;310(6):591-608. doi: 10.1001/jama.2013.13805.
5
Advances in the development of vaccines for Alzheimer's disease.阿尔茨海默病疫苗研发进展
Discov Med. 2013 May;15(84):319-26.
6
Monetary costs of dementia in the United States.美国痴呆症的货币成本。
N Engl J Med. 2013 Apr 4;368(14):1326-34. doi: 10.1056/NEJMsa1204629.
7
Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.我们能否预防阿尔茨海默病？阿尔茨海默病的二级“预防”试验。
Alzheimers Dement. 2013 Mar;9(2):123-131.e1. doi: 10.1016/j.jalz.2012.12.004. Epub 2013 Feb 12.
8
Clinical and biomarker changes in dominantly inherited Alzheimer's disease.常染色体显性遗传阿尔茨海默病的临床和生物标志物变化。
N Engl J Med. 2012 Aug 30;367(9):795-804. doi: 10.1056/NEJMoa1202753. Epub 2012 Jul 11.
9
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.阿尔茨海默病预防计划：加速评估前驱期治疗的计划。
J Alzheimers Dis. 2011;26 Suppl 3(Suppl 3):321-9. doi: 10.3233/JAD-2011-0059.
10
Initial sequencing and analysis of the human genome.人类基因组的初步测序与分析。
Nature. 2001 Feb 15;409(6822):860-921. doi: 10.1038/35057062.
Zotero 插件